Lawsuit Overview
September 12, 2016 (Shareholders Foundation) - An investor in shares of Bristol-Myers Squibb Co (NYSE:BMY) filed a lawsuit against certain directors of Bristol-Myers Squibb over alleged breaches of fiduciary duties. The plaintiff alleges that Bristol-Myers Squibb illegally bribed Chinese officials to increase business and to line their own pockets. In October 2015, Bristol-Myers Sq...
You must register (for free) or login to view the entire case.